Development and evaluation of a real-time RT-PCR assay for quantification of cell-free human immunodeficiency virus type 2 using a Brome Mosaic Virus internal control

Journal of Virological Methods

Volumn 135, Issue 1, 2006, Pages 102-108

  Ferns, R B ^a   Garson, J A ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Antiretroviral therapy; HIV 2; Human immunodeficiency virus type 2; Real time RT PCR; TaqMan; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT; COMPLEMENTARY DNA; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; DEVELOPMENT; DNA SYNTHESIS; GENE AMPLIFICATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL ASSESSMENT; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; RISK FACTOR; RNA PURIFICATION; SENSITIVITY AND SPECIFICITY; VIRUS DETECTION;

ANALYSIS OF VARIANCE; BROMOVIRUS; HIV INFECTIONS; HIV-2; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

BROME MOSAIC VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 33646589636     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2006.02.005     Document Type: Article

References (25)

1. Altschul S.F., Gish W., Miller W., Myers E.W., and Lipman D.J. Basic local alignment search tool. J. Mol. Biol. 215 (1990) 403-410
2. Berry N., Ariyoshi K., Jobe O., Ngum P.T., Corrah T., Wilkins A., Whittle H., and Tedder R.S. HIV type 2 proviral load measured by quantitative polymerase chain reaction correlates with CD4+ lymphopenia in HIV type 2-infected individuals. AIDS Res. Hum. Retroviruses 10 (1994) 1031-1037
3. Berry N., Ariyoshi K., Jaffar S., Sabally S., Corrah T., Tedder R., and Whittle H. Low and perhipheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection. J. Hum. Virol. 1 (1998) 457-468
4. Boom R., Sol C.J.A., Salimans M.M.M., Jansen C.L., Wertheim-van Dillen P.M.E., and van der Noordaa J. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28 (1990) 495-503
5. Chen Z., Luckay A., Sodora D.L., Telfer P., Reed P., Gettie A., Kanu J.M., Sadek R.F., Yee J., Ho D.D., Zhang L., and Marx P.A. Human immunodeficiency virus type 2 (HIV-2) seroprevalence and characterization of a distinct HIV-2 genetic subtype from the natural range of simian immunodeficiency virus-infected sooty mangabeys. J. Virol. 71 (1997) 3953-3960
6. Clavel F., Guetard D., Brun-Vezinet F., Chamaret S., Rey M.A., Santos-Ferreira M.O., Laurent A.G., Dauguet C., Katlama C., Rouzioux C., Klatzmann D., Champalimaud J.L., and Montagnier L. Isolation of a new human retrovirus from West African patients with AIDS. Science 223 (1986) 343-346
7. Colson P., Henry M., Tivoli N., Gallais H., Gastaut J.A., Moreau J., and Tamalet C. Polymorphism and drug-selected mutations in the reverse transcriptase gene of HIV-2 from patients living in southeastern France. J. Med. Virol. 75 (2005) 381-390
8. Damond F., Gueudin M., Pueyo S., Farfara I., Robertson D.L., Descamps D., Chene G., Matheron S., Campa P., Brun-Vezinet F., and Simon F. Plasma RNA viral load in human immunodeficiency virus type 2 subtype A and subtype B infections. J. Clin. Microbiol. 40 (2002) 3654-3659
9. Damond F., Collin G., Descamps D., Matheron S., Pueyo S., Taieb A., Campa P., Benard A., Chene G., and Brun-Vezinet F. Improved sensitivity of human immunodeficiency virus type 2 subtype B plasma viral load assay. J. Clin. Microbiol. 43 (2005) 4234-4236
10. De Cock K.M., Adjorlolo G., Ekpini E., Sibailly T., Kouadio J., Maran M., Brattegaard K., Vetter K.M., Doorly R., and Gayle H.D. Epidemiology and transmission of HIV-2: why there is no HIV-2 pandemic. JAMA 270 (1993) 2083-2086
11. Descamps D., Damond F., Matheron S., Collin G., Campa P., Delarue S., Pueyo S., Chene G., Brun-Vezinet F., and The French ANRS HIV-2 Cohort Study Group. High frequency of selection of K65R and Q151M mutations in HIV-2 infected patients receiving nucleoside reverse transcriptase inhibitors containing regimen. J. Med. Virol. 74 (2004) 197-201
12. Garson J.A., Grant P.R., Ayliffe U., Ferns R.B., and Tedder R.S. Real-time PCR quantitation of hepatitis B virus DNA using automated sample preparation and murine cytomegalovirus internal control. J. Virol. Methods 126 (2005) 207-213
13. Gibellini D., Vitone F., Gori E., La Placa M., and Re M.C. Quantitative detection of human immunodeficiency virus type 1 (HIV-1) viral load by SYBR green real-time RT-PCR technique in HIV-1 seropositive patients. J. Virol. Methods 115 (2004) 183-189
14. Hahn B.H., Shaw G.M., De Cock K.M., and Sharp P.M. AIDS as a zoonosis: scientific and public health implications. Science 287 (2000) 607-614
15. Mackay I.M., Arden K.E., and Nitsche A. Real-time PCR in virology. Nucleic Acids Res. 30 (2002) 1292-1305
16. Marlink R. Lessons from the second AIDS virus, HIV-2. AIDS 10 (1996) 689-699
17. Mellors J.W., Rinaldo C.R.J., Gupta P., White R.M., Todd J.A., and Kingsley L.A. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272 (1996) 1167-1170
18. Rey M.A., Krust B., Laurent A.G., Guetard D., Montagnier L., and Hovanessian A.G. Characterization of an HIV-2-related virus with a smaller sized extracellular envelope glycoprotein. Virology 173 (1989) 258-267
19. ® for the detection of human immunodeficiency virus type 2 (HIV-2). J. Virol. Methods 117 (2004) 67-74
20. Rodrigo A.G., Goracke P.C., Rowhanian K., and Mullins J.I. Quantitation of target molecules from polymerase chain reaction-based limiting dilution assays. AIDS Res. Hum. Retroviruses 13 (1997) 737-742
21. Schulz T.F., Whitby D., Hoad J., Corrah T., Whittle H., and Weiss R. Biological and molecular variability of human immunodeficiency virus type 2 isolates from the Gambia. J. Virol. 64 (1990) 5177-5182
22. Schutten M., van den Hoogen B., van der Ende M.E., Gruters R.A., Osterhaus A.D.M.E., and Niesters H.G.M. Development of a real-time quantitative RT-PCR for the detection of HIV-2 RNA in plasma. J. Virol. Methods 88 (2000) 81-87
23. Smith N.A., Shaw T., Berry N., Vella C., Okorafor L., Taylor D., Ainsworth J., Choudhury A., Daniels R.S., El-Gadi S., Fakoya A., Moyle G., Oxford J., Tedder R., O'Shea S., de Ruiter A., and Breuer J. Antiretroviral therapy for HIV-2 infected patients. J. Infect. 42 (2001) 126-133
24. Soriano V., Gomes P., Heneine W., Holguin A., Doruana M., Antunes R., Mansinho K., Switzer W.M., Araujo C., Shanmugam V., Lourenco H., Gonzalez-Lahoz J., and Antunes F. Human immunodeficiency virus type 2 (HIV-2) in Portugal: clinical spectrum, circulating subtypes, virus isolation, and plasma viral load. J. Med. Virol. 61 (2000) 111-116
25. Thompson J.D., Gibson T.J., Plewniak F., Jeanmougin F., and Higgins D.G. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25 (1997) 4876-4882